Fredun Pharma's Freossi Division marks its entry into Sri Lanka with a Suite of Premium Quality Petcare Products

Fredun Pharmaceuticals Limited (BSE: 539730), a leading provider of pharmaceuticals and innovative healthcare solutions for human & veterinary applications, proudly announces the international expansion of its pet care division, Freossi. With the introduction of 9 premium-quality products in Sri Lanka and a pipeline of over 20 products with the Department of Animal Production and Health (DAPH) in Sri Lanka which is the regulatory authority for veterinary products. The launch was inaugurated by noteworthy & esteemed Prof. Ashoka Dangolla (BVSc (Peradeniya), Dip Vet Epid (Helsinki), PhD (KVL, Denmark)Professor), HOD of Veterinary Clinical Science, Faculty of Veterinary Medicine & Animal Science. This significant venture marks Freossi's first foray outside of India, underscoring the company's dedication to becoming a holistic provider of animal healthcare.

Freossi's mission is to offer premium quality pet food and grooming products that enhance the health, happiness, and well-being of pets worldwide. Each product in the Freossi range is formulated with the utmost attention to detail, utilizing only the highest quality ingredients. In collaboration with veterinary experts, nutritionists, and grooming specialists, Freossi develops products that meet the diverse needs of pets and the high expectations of their owners.

Commenting on the Development, Mr. Fredun Medhora, Managing Director, said: "The enthusiasm with which our Freossi products have been welcomed in Sri Lanka is incredibly heartening. The positive feedback from doctors, HoDs, pet owners and industry experts reaffirm our dedication to delivering exceptional quality and commitment to pet welfare. We are eager to continue nurturing the Sri Lankan market and to make a meaningful contribution to the lives of pets and their caretakers."

The newly launched products in Sri Lanka include under MCHC range, functional range, Therapeutic range, grooming range, which have already garnered a favorable response for their quality and effectiveness. The launch event was a resounding success, attended by key figures in the veterinary and pet care industry, as well as local distributors and partners. With this expansion, Fredun Pharma aims to establish Freossi as a leading brand in the Sri Lankan pet care market and is excited about future opportunities to enhance the lives of pets globally. The common dialogue of this fraternity was "Fredun's expansion with Freossi in Sri Lanka gives assurance that it will enhance the health and well-being of livestock and companion animals across the island."

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 696.70 as compared to the previous close of Rs. 678.05. The total number of shares traded during the day was 3605 in over 121 trades.

The stock hit an intraday high of Rs. 703.00 and intraday low of 678.05. The net turnover during the day was Rs. 2501351.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals INE194R01017 FreossiDivision SriLanka PetcareProducts